Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.55 |
| ▸ | TDO2 | P48775 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.53 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.53 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.53 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.53 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.53 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.53 |
| ▸ | GABRP | O00591 | 2/20 | 0.53 |
| ▸ | GABRD | O14764 | 2/20 | 0.53 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.53 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.53 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.53 |
| ▸ | GABRE | P78334 | 2/20 | 0.53 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.53 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.53 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.53 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL458963 | 1.00 | KIF11 (0.55) | KIF11TDO2KDM4EMAPTGABRA1 | |
| SCHEMBL25298405 | 0.95 | KDM4E (0.55) | KIF11TDO2KDM4EMAPTGABRA1 | |
| SCHEMBL31682284 | 0.95 | KDM4E (0.55) | KIF11TDO2KDM4EMAPTGABRA1 | |
| SCHEMBL27842256 | 0.89 | KIF11 (0.45) | KIF11TDO2KDM4EMAPTGABRA1 | |
| SCHEMBL27884581 | 0.88 | KIF11 (0.44) | KIF11TDO2KDM4EMAPTGABRA1 | |
| SCHEMBL21382671 | 0.87 | KIF11 (0.43) | KIF11TDO2KDM4EMAPTGABRA1 | |
| SCHEMBL26675637 | 0.84 | PARP1 (0.51) | KIF11KDM4EMAPTGABRA1GABRG2 | |
| SCHEMBL28533079 | 0.83 | TDO2 (0.40) | KIF11TDO2KDM4EMAPTGABRA1 | |
| SCHEMBL170598 | 0.83 | TDO2 (0.42) | KIF11TDO2KDM4EMAPTGABRA1 | |
| SCHEMBL32691812 | 0.81 | TDO2 (0.51) | KIF11TDO2KDM4EMAPTGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4715043-A1 | METHOD FOR PRODUCING NEURAL CREST CELLS | Kyoto University (JP) | 2026-03-25 | — | — | EP | disclosed |
| WO-2026007509-A1 | PYRIDOCARBAZOLE TETRADENTATE PLATINUM (II) COMPLEX, ELECTRONIC DEVICE, APPARATUS AND USE THEREOF | 浙江工业大学 | 2026-01-08 | — | — | WO | disclosed |
| US-20250122193-A1 | NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF | LARSSON, Lars-Gunnar Olof (SE) | 2025-04-17 | — | — | US | disclosed |
| EP-4452268-A1 | NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF | MyCural Therapeutics AB (SE) | 2024-10-30 | — | — | EP | disclosed |
| EP-4452268-A1 | NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF | MyCural Therapeutics AB (SE) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023118893-A1 | NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF | MYCURAL THERAPEUTICS (SE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023118893-A1 | NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF | MYCURAL THERAPEUTICS (SE) | 2023-06-29 | — | — | WO | disclosed |
| US-11401268-B2 | Organic compound having improved luminescent properties, organic light emitting diode and organic light emitting device having the compound | LG DISPLAY CO., LTD. (KR) | 2022-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122193-A1 | NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF | MYC, MYCBP, REL | KIF11 3100/4885TDO2 3457/4885KDM4E 2079/4885 |
| US-11401268-B2 | Organic compound having improved luminescent properties, organic light emitting diode and organic light emitting device having the compound | DNMT1, ACR, NLRP1 | KIF11 2316/4885TDO2 3223/4885KDM4E 1255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.